亞太地區 MRD 檢測市場：分析與預測（2023-2033）

亞太地區MRD（微量殘存疾病）檢測市場規模預計將從2023年的3億美元增加至2033年的13.3億美元，2023-2033年預測期間複合年成長率為16.06%。

MRD 檢測市場正在擴大，原因有很多，包括擴大 MRD 檢測的醫療保險覆蓋範圍及其在固體癌診斷中的應用。消費者意識的提高增加了對 MRD 檢測的需求。醫療保健專業人員和研究人員正在認知到這一趨勢，並將 MRD 檢測融入臨床實踐，以滿足患者的需求。

由於多種因素，亞太地區 MRD 檢測市場正在經歷顯著成長。這包括擴大 MRD 檢測的醫療保健覆蓋範圍以及 MRD 檢測在固體癌診斷中的新作用。消費者對 MRD 檢測的認知不斷提高，導致全部區域對 MRD 檢測的需求激增。醫療保健專業人員和研究人員已經認知到這一趨勢，並積極致力於將 MRD 檢測涵蓋常規臨床程序，以有效滿足患者需求。此外，亞太地區主要國家技術和醫療基礎設施的進步進一步促進了 MRD 檢測市場的擴大。亞太地區日益重視早期檢測和精準醫療，這為 MRD 檢測提供者和相關人員帶來了巨大的機會。

本報告考察了亞太地區 MRD 檢測市場，並提供了市場概述、最終用戶、國家/地區的趨勢以及參與市場的公司概況。

目錄

執行摘要

第1章 市場

• 市場範圍
• 調查方法
• 市場估算模型

第2章 市場概況

• MRD檢查流程分析
• MRD 檢測：固態腫瘤與骨髓惡性腫瘤
• MRD 檢測的演變
• 市場足跡
• 市場規模及未來成長潛力

第3章業界考察

• MRD 檢測的法律和法律規範
• 贖回場景
• 供應鏈分析
  • 用於實驗室開發測試 (LDT)
  • 用於體外診斷 (IVD)

第4章 MRD 檢測市場（按地區），2022-2033

• 概述
• 亞太地區
  • 亞太地區 MRD 檢測市場（依最終用戶）
  • 亞太地區 MRD 檢測市場（按國家/地區）

第5章 公司簡介

• Sysmex Corporation

The Asia-Pacific MRD Testing Market Expected to Reach $1.33 Billion by 2033

Introduction to Asia-Pacific MRD Testing Market

The Asia-Pacific MRD testing market is projected to reach $1.33 billion by 2033 from $0.30 billion in 2023, growing at a CAGR of 16.06% during the forecast period 2023-2033. The MRD testing market is expanding due to several reasons, including the expansion of Medicare coverage for MRD testing and its application in diagnosing solid tumors. Increased consumer awareness has led to a heightened demand for MRD testing. Healthcare practitioners and researchers are recognizing this trend and endeavouring to integrate MRD testing into clinical practices to address patient needs.

Market Introduction

The Asia-Pacific (APAC) MRD testing market is witnessing significant growth driven by various factors. This includes the extension of healthcare coverage for MRD testing and its emerging role in diagnosing solid tumors. Increasing awareness among consumers has led to a surge in demand for MRD testing across the region. Healthcare professionals and researchers are recognizing this trend and actively working to incorporate MRD testing into routine clinical procedures to meet patient needs effectively. Additionally, advancements in technology and healthcare infrastructure in key APAC countries further contribute to the expansion of the MRD testing market. With a growing emphasis on early detection and precision medicine, the APAC region presents substantial opportunities for MRD testing providers and stakeholders.

Market Segmentation:

Segmentation 1: by End User

• Hospitals and Speciality Clinics
• Research Institutions
• Diagnostic Laboratories
• Other End Users

Segmentation 2: by Country

• China
• India
• Japan
• South Korea
• Australia
• Singapore
• Rest-of-Asia-Pacific

How Can This Report Add Value to an Organization?

Growth/Marketing Strategy: The APAC MRD testing market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture. The favored strategy for the companies has been partnerships and collaborations to strengthen their position in the MRD testing market.

Competitive Strategy: Key players in the APAC MRD testing market analyzed and profiled in the study involve major residual testing-based companies and test manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the APAC MRD testing market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Table of Contents

Executive Summary

1 Markets

• 1.1 Market Scope
  • 1.1.1 Key Questions Answered in the Report
• 1.2 Research Methodology
  • 1.2.1 MRD Testing Market: Research Methodology
  • 1.2.2 Data Sources
• 1.3 Market Estimation Model
  • 1.3.1 Criteria for Company Profiling

2 Market Overview

• 2.1 MRD Testing Workflow Analysis
• 2.2 MRD Testing: Solid Tumor vs. Hematological Malignancy
• 2.3 Evolution of MRD Testing
• 2.4 Market Footprint
• 2.5 Market Size and Future Growth Potential

3 Industry Insights

• 3.1 Legal and Regulatory Framework of MRD Tests
  • 3.1.1 Asia-Pacific
• 3.2 Reimbursement Scenario
  • 3.2.1 Asia-Pacific
• 3.3 Supply Chain Analysis
  • 3.3.1 For Laboratory Developed Tests (LDTs)
  • 3.3.2 For In-Vitro Diagnostics (IVDs)

4 Minimal Residual Disease Testing Market (by Region), 2022-2033

• 4.1 Overview
• 4.2 Asia-Pacific
  • 4.2.1 Asia-Pacific MRD Testing Market, by End User
  • 4.2.2 Asia-Pacific MRD Testing Market, by Country

5 Company Profiles

• 5.1 Overview
• 5.2 Sysmex Corporation
  • 5.2.1 Company Overview
  • 5.2.2 Role of Sysmex Corporation in the MRD Testing Market
  • 5.2.3 Financials
  • 5.2.4 Analyst Perspective

List of Figures

• Figure 1: Asia-Pacific MRD Testing Market, $Billion, 2022 and 2033
• Figure 2: Share of Asia-Pacific MRD Testing Market (by End User), $Billion, 2022 and 2033
• Figure 3: Share of MRD Testing Market (by Region), 2022
• Figure 4: MRD Testing Market: Research Methodology
• Figure 5: Primary Research Methodology
• Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
• Figure 7: Top-Down Approach (Segment-Wise Analysis)
• Figure 8: MRD Testing Workflow
• Figure 9: Evolution of the MRD Testing Market
• Figure 10: Asia-Pacific MRD Testing Market Potential, $Billion, 2022-2033
• Figure 11: Supply Chain Analysis of Laboratory-Developed Tests
• Figure 12: Supply Chain Analysis of In-Vitro Diagnostics
• Figure 13: MRD Testing Market Snapshot (by Region)
• Figure 14: Asia-Pacific: Market Dynamics
• Figure 15: Asia-Pacific MRD Testing Market, $Billion, 2022-2033
• Figure 16: Asia-Pacific MRD Testing Market (by End User), $Million, 2022-2033
• Figure 17: Asia-Pacific MRD Testing Market (by Country), $Million, 2022-2033
• Figure 18: China MRD Testing Market, $Million, 2022-2033
• Figure 19: India MRD Testing Market, $Million, 2022-2033
• Figure 20: Japan MRD Testing Market, $Million, 2022-2033
• Figure 21: South Korea MRD Testing Market, $Million, 2022-2033
• Figure 22: Australia MRD Testing Market, $Million, 2022-2033
• Figure 23: Singapore MRD Testing Market, $Million, 2022-2033
• Figure 24: Rest-of-Asia-Pacific MRD Testing Market, $Million, 2022-2033
• Figure 25: MRD Testing Market, Total Number of Companies Profiled
• Figure 26: Sysmex Corporation: Product Portfolio
• Figure 27: Sysmex Corporation: Overall Financials, $Million, 2020-2022
• Figure 28: Sysmex Corporation: Revenue (by Segment), $Million, 2020-2022
• Figure 29: Sysmex Corporation: Revenue (by Region), $Million, 2020-2022
• Figure 30: Sysmex Corporation: R&D Expenditure, $Million, 2020-2022

List of Tables

• Table 1: Impact Analysis of Market Drivers, Challenges, and Opportunities in the MRD Testing Market
• Table 2: Comparison of Solid Tumor and Hematological Malignancy for MRD Testing
• Table 3: Registration Criteria for IVD Medical Devices as per CFDA